R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

PURPOSE: The type 1 insulin-like growth factor 1 receptor (IGF-1R) has been implicated in the pathogenesis of the Ewing sarcoma family of tumors (ESFT). We conducted a multicenter phase II study of the fully human IGF-1R monoclonal antibody R1507 in patients with recurrent or refractory ESFT. PATIEN...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Pappo, Alberto S., Patel, Shreyaskumar R., Crowley, John, Reinke, Denise K., Kuenkele, Klaus-Peter, Chawla, Sant P., Toner, Guy C., Maki, Robert G., Meyers, Paul A., Chugh, Rashmi, Ganjoo, Kristen N., Schuetze, Scott M., Juergens, Heribert, Leahy, Michael G., Geoerger, Birgit, Benjamin, Robert S., Helman, Lee J., Baker, Laurence H.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2011
Teme:
Original Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3236654/
https://ncbi.nlm.nih.gov/pubmed/22025149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.34.0000
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items